Lv11
20 积分 2024-06-07 加入
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
1小时前
待确认
Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site
2小时前
求助中
Neoadjuvant gemcitabine–cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial
14天前
已完结
Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metastatic disease
1个月前
已完结
Right Ureteral Carcinoma Suggested by 99mTc-DTPA Renography in a Patient With Left Pyelocaliceal Carcinoma
2个月前
已完结
Correction of differential renal function for asymmetric renal area ratio in unilateral hydronephrosis
2个月前
已完结
Contradictory Supranormal Differential Renal Function During Nuclear Renographic Investigation of Hydroureteronephrosis
2个月前
已完结
Ureteropelvic junction obstruction with polyps in children: clinical manifestations and supranormal preoperative differential renal function
2个月前
已完结
Supranormal renal function in unilateral hydronephrosis: does it represent true hyperfunction?
2个月前
已完结
Influence of preoperative hydronephrosis on the outcome of urothelial carcinoma of the upper urinary tract after nephroureterectomy: the results from a multi-institutional French cohort
2个月前
已完结
皖公网安备34019202002308
